Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from HealthCare Global Enterprises Ltd. ( (IN:HCG) ) is now available.
KKR, a global investment firm, has acquired a controlling stake in Healthcare Global Enterprises (HCG), a leading oncology hospital chain in India, for $400 million. KKR is set to own between 54-77% equity in HCG, marking its latest investment in the Indian healthcare sector. Dr. BS Ajaikumar, the founder of HCG, will remain involved as the Non-Executive Chairman, focusing on clinical, academic, and research excellence. This acquisition is expected to enhance HCG’s service offerings and expand its reach in cancer care, supported by KKR’s global expertise in healthcare.
More about HealthCare Global Enterprises Ltd.
Healthcare Global Enterprises Limited (HCG) is one of India’s largest oncology hospital chains, founded in 1989. It operates 25 medical care centers across 19 cities and is equipped with state-of-the-art infrastructure, including 2,500 beds, nearly 100 operating theaters, and 40 linear accelerator machines. HCG is recognized as a leader in cancer care in India.
YTD Price Performance: 2.95%
Average Trading Volume: 19,389
Current Market Cap: 69.7B INR
Learn more about HCG stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue